NYEE HomeThe New York Eye and Ear Infirmary
Patient InfoHealthcare ProfessionalsSpecialties & ServicesSupport NYEEAbout Us
  Current Research
Clinical Trials in Ophthalmology
Ophthalmology
Research

Otolaryngology
Research

Pathology
& Laboratory Medicine
Research

Plastic &
Reconstructive
Surgery
Research

Institutional
Review Board
(IRB)

 
printer-friendly version of this pagePrinter-Friendly Page large print version of this pageLarge Print Version 

Serial Retinal Thickness Changes and Scotoma Size Measured with Lucentis Therapy measured Using the OCT Ophthalmoscope (OCT/SLO)® and the Foresee Preferential Hyperacuity Perimeter TM PROTOCOL FVF4193s


Principal Investigator: Richard Rosen, MD

Enrollment Status: Open Enrollment

Objective:  To evaluate the efficacy of intravitreal bevasiranib sodium as maintenance therapy for Age-Related Macular Degeneration following initiation of anti-VEGF therapy with 3 doses of Lucentis®

Eligibility: 

Contact Information:  Jenny Gallardo, CRC (212)-614-8386; Katy Tai, CR Manager (212) 979-4251

 

Home > Current Research > Clinical Trials in Ophthalmology > SERIAL RETINAL THICKNESS CHANGES AND SCOTOMA SIZE MEASURED WITH LUCENTIS THERAPY MEASURED USING THE OCT OPHTHALMOSCOPE (OCT/SLO)® AND THE FORESEE PREFERENTIAL HYPERACUITY PERIMETER TM PROTOCOL FVF4193S